INDIANAPOLIS, July 19, 2011 /PRNewswire/ -- Data were presented today from the first of two Phase III trials of semagacestat, including data from a 32 week follow-up period after dosing was halted in August 2010. Semagacestat is a gamma secretase inhibitor that had been studied as a potential treatment for Alzheimer's disease. Results shown today provided patient outcomes from the active treatment portion of the study and from a modified portion of the study conducted after dosing with semagacestat was stopped. Lilly presented the data during a plenary session at the Alzheimer's Association International Conference 2011 (AAIC 2011) in Paris, France.
PR News Wire
More Stories
July 19 TESTING - TESTING - TESTING
AMSTERDAM, July 19, 2011 /PRNewswire/ --
LEAMINGTON SPA, England, July 19, 2011 /PRNewswire/ --
LONDON, July 19, 2011 /PRNewswire/ --
LIMASSOL, Cyprus, July 19, 2011 /PRNewswire/ --
July 19 TESTING - TESTING - TESTING
D-Link Integrates OpenDNS on Select Routers to Offer Cloud-Based Parental Controls on Network-Connected Devices
FOUNTAIN VALLEY, Calif., July 19, 2011 /PRNewswire/ -- D-Link today announced the integration of OpenDNS technology into select D-Link® routers, enabling households to block unsafe and inappropriate Web content such as adult and phishing websites – all right at the source of the home network – the router. With OpenDNS technology, D-Link routers offer consumers Web content filtering and security services, ensuring that all connected devices in the household, from laptops to gaming consoles, are guarded from unsuitable online content via the built-in and fully customizable OpenDNS parental control solution.
July 19 TESTING - TESTING - TESTING
PARIS, July 19, 2011 /PRNewswire/ --
Inaugural Quarterly Report from TBG Digital Analyses 200 Billion Impressions from 167 Clients to Highlight Advertising Effectiveness and Consumer Behaviour on Facebook
LONDON, July 19, 2011 /PRNewswire/ --
TAUNTON, England, July 19, 2011 /PRNewswire/ --
July 19 TESTING - TESTING - TESTING
VANCOUVER, July 19, 2011 Toronto Stock Exchange (Venture) Symbol: "WND" Issued and Outstanding: 59,856,524
July 19 TESTING - TESTING - TESTING
BETHESDA, MD, July 19, 2011 -- Adventurers and Youth Ambassadors ran marathons in Bolivia's Andes mountains to promote the United Nations' International Year of Chemistry --
A state-of-the-art luxurious health and beauty clinic with a unique one-of-a-kind concept, unavailable in either the medical or spa industries, has opened on the French Riviera to worldwide acclaim.
CAP D'ANTIBES, France, July 19, 2011 /PRNewswire/ -- Since opening its doors last month, Le Clinique Science & Beaute has received glowing reviews from its clients, ranging from celebrities and VIPs to stressed out executives, athletes and jet-setters, making it a resounding success for a venue to go and rejuvenate, in just a matter of weeks.
CAMBRIDGE, England, July 19, 2011 /PRNewswire/ --
PARIS, July 19, 2011 Mathematical Model Still Needs "Real World" Proof
July 19 TESTING - TESTING - TESTING
In Print
